GKCAS 2018 Annual Allergy & Immunology Symposium
Didactic lectures allow the speakers to provide evidence based medical recommendations, updates and expert opinion in an efficient manner held in a one day meeting.
Practicing allergists, physicians and allied health professionals.
Upon completion of this session, participants should be able to:
• Distinguish between patients who will benefit from traditional treatment modalities versus the addition of a biologic to manage their atopic dermatitis.
• Identify the appropriate treatment modality for each individual patient and what patient profile would benefit from consideration for treatment with a biologic.
• Recommend, via counseling, the appropriate treatment modality, including consideration for treatment with a biologic, based on the evidence based management approach along with patient preference and potential adverse effects.
• Recommend strategies for long-term monitoring when using biologic therapies.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Greater Kansas City Allergy Society (GKCAS). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 4.00 AMA PRA Category 1 Credit™
- 4.00 Attendance